Clinical trials
Observational Myopia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 4 |
| 2020 | 10 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 17 |
| Recruiting | 10 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tianjin Eye Hospital | 16 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 5 |
| Shanghai Eye Disease Prevention and Treatment Center | 4 |
| Sun Yat-sen University | 4 |
| Beijing Tongren Hospital | 3 |
| Aier School of Ophthalmology, Central South University | 2 |
| Peking University Third Hospital | 2 |
| Second Affiliated Hospital of Nanchang University | 2 |
| Wenzhou Medical University | 2 |
| Beijing Visionly Plus Eye Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myopia | 55 |
| Refractive Errors | 12 |
| Astigmatism | 3 |
| Cataract | 3 |
| COVID-19 | 1 |
| Eye Diseases | 1 |
| Glaucoma | 1 |
| Glaucoma, Open-Angle | 1 |
| Ocular Motility Disorders | 1 |
| Presbyopia | 1 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.